These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass. Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162 [TBL] [Abstract][Full Text] [Related]
5. Investigation of a thrombin inhibitor peptide as an alternative to heparin in cardiopulmonary bypass surgery. Chomiak PN; Walenga JM; Koza MJ; Reilly TM; Turlapathy P; Pifarre R Circulation; 1993 Nov; 88(5 Pt 2):II407-12. PubMed ID: 7993389 [TBL] [Abstract][Full Text] [Related]
6. Clinical use of heparin-coated cardiopulmonary bypass in coronary artery bypass grafting. Mirow N; Minami K; Kleikamp G; Tenderich G; Puhlmann T; Körfer R Thorac Cardiovasc Surg; 2001 Jun; 49(3):131-6. PubMed ID: 11432470 [TBL] [Abstract][Full Text] [Related]
7. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs. Bagge L; Borowiec JW; Thelin S; Hultman J Scand Cardiovasc J; 1997; 31(5):275-81. PubMed ID: 9406294 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of factor IXa by the pegnivacogin system during cardiopulmonary bypass: a potential substitute for heparin. A study in baboons. Bel A; Borik W; Davidson S; Helies JM; Stimmer L; Fremes S; Zelenkofske S; Rusconi C; Alexander J; Alexander D; Menasché P; Pepper J Eur J Cardiothorac Surg; 2016 Feb; 49(2):682-9. PubMed ID: 25953802 [TBL] [Abstract][Full Text] [Related]
10. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs. Bagge L; Borowiec JW; Thelin S; Hultman J Scand Cardiovasc J; 1997; 31(6):275-81. PubMed ID: 9498931 [TBL] [Abstract][Full Text] [Related]
11. Descending thoracic aortic aneurysm repair with the aid of partial cardiopulmonary bypass: heparin-coated circuits versus nonheparin-coated circuits. Morishita K; Kawaharada N; Fukada J; Hachiro Y; Kurimoto Y; Fujisawa Y; Saito T; Abe T Artif Organs; 2005 Apr; 29(4):300-5. PubMed ID: 15787624 [TBL] [Abstract][Full Text] [Related]
12. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass. Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115 [TBL] [Abstract][Full Text] [Related]
13. Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits. Borowiec J; Bagge L; Saldeen T; Thelin S Thorac Cardiovasc Surg; 1997 Aug; 45(4):163-7. PubMed ID: 9323816 [TBL] [Abstract][Full Text] [Related]
14. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass. Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453 [TBL] [Abstract][Full Text] [Related]
15. [Measurement of activated clotting time during cardiopulmonary bypass in infective endocarditis patients]. Jiang L; Yu JF Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):167-9. PubMed ID: 17344611 [TBL] [Abstract][Full Text] [Related]
16. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit. Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027 [TBL] [Abstract][Full Text] [Related]
17. Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass. Gruenwald CE; Manlhiot C; Chan AK; Crawford-Lean L; Foreman C; Holtby HM; Van Arsdell GS; Richards R; Moriarty H; McCrindle BW J Am Coll Cardiol; 2010 Nov; 56(22):1794-802. PubMed ID: 21087706 [TBL] [Abstract][Full Text] [Related]
18. Baboon veno-arterial cardiopulmonary bypass without anticoagulants. Fletcher JR; McKee A; Anderson R; Watson L Trans Am Soc Artif Intern Organs; 1978; 24():315-9. PubMed ID: 102058 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update. Despotis GJ; Joist JH J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245 [TBL] [Abstract][Full Text] [Related]
20. Attenuated renal and intestinal injury after use of a mini-cardiopulmonary bypass system. Huybregts RA; Morariu AM; Rakhorst G; Spiegelenberg SR; Romijn HW; de Vroege R; van Oeveren W Ann Thorac Surg; 2007 May; 83(5):1760-6. PubMed ID: 17462395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]